DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Interferon alpha-2B
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
34
神経線維腫症
1
34. 神経線維腫症
臨床試験数
:
133
/
薬物数
:
186
- (
DrugBank
:
67
) /
標的遺伝子数
:
79
-
標的パスウェイ数
:
190
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT00846430
(
ClinicalTrials.gov
)
October 2008
20081000
16/1/2009
20090116
Medical Treatment of High-Risk Neurofibromas
Medical Treatment of High-Risk Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical Trial of Sequential Medical Therapies
Medical Treatment of High-Risk Neurofibromas in Patients With Type 1 Neurofibromatosis: A Clinical T ...
Neurofibromatosis 1
Drug: Peg-
Interferon
alpha-2b
;Drug: Celecoxib (Celebrex);Drug: Temozolomide (temodar);Drug: Vincristine Sulfate (Oncovin)
Drug: Peg-
Interferon
alpha-2b
;Drug: Celecoxib (Celebrex);Drug: Temozolomide (temodar);Drug: Vincrist ...
Spectrum Health Hospitals
NULL
Completed
2 Years
30 Years
All
11
Phase 2
United States